(Q47365108)

English

Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

0 references

Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jolanta M Siller-Matula

9

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

Antonino Buffon

object named as

A Buffon

8

0 references

object named as

J Kubica

12

0 references

author name string

E P Navarese

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

G De Luca

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

F Castriota

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

M Kozinski

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

P A Gurbel

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

C M Gibson

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

F Andreotti

7

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

A Sukiennik

10

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

S De Servi

11

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

9

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

10

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

1902-1915

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Guidelines on myocardial revascularization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Analysis of data from multiclinic trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

The relation between treatment benefit and underlying risk in meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin vs. non-fractionated heparin in primary angioplasty of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Prehospital administration of enoxaparin before primary angioplasty for ST-elevation acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04445.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2011.04445.X

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/21777368

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47365108&oldid=2153748159"